“Danisco is a premier company, a long-time successful partner of DuPont and a proven innovator committed to sustainable growth,” said DuPont chair and CEO, Ellen Kullman. “Danisco has attractive, market-driven science businesses that offer clear synergies with DuPont Nutrition & Health and Applied BioSciences.”
The acquisition is expected to be financed with about $3bn in existing cash and the remainder in debt. The transaction is expected to close early in the second quarter.
Source: DuPont
© FoodBev Media Ltd 2024